| | | |  | | | | By Ed Silverman and Jonathan Wosen Alex Hogan/STAT, Adobe Gilead and Johnson & Johnson have been hit by a sweeping and sophisticated counterfeit drug scheme involving HIV medicines. Read More | | By Usha Lee McFarling Spencer Platt/Getty Images Undetected low oxygen levels led to delays in Black and Hispanic patients receiving therapies such as the drugs remdesivir and dexamethasone. Read More | | By Nicholas Florko Adobe The American Medical Association is fighting an otherwise popular bill that would require training doctors about opioid use disorder. Read More | | Sponsor content by Exact Sciences Accelerating the cancer moonshot through collaboration Today's moonshot is undoubtedly cancer, and the time to act is now. Eradicating cancer or, at the very least, turning it into a much more manageable disease — is an audacious goal. Yet, if we invest today, it is something our children and grandchildren will live to see. Learn more about cancer innovations and options in earlier detection. | | By Ed Silverman FABRICE COFFRINI/AFP/Getty Images Documents reviewed by STAT illustrate issues at a Novartis facility where production of a cancer treatment was halted this month. Read More | | By Usha Lee McFarling Darren Hauck/Getty Images Medical students who report being mistreated or discriminated against are far more likely to drop out of medical school, a new study finds. Read More | | By Sylvie Leotin Adobe To uproot health inequities in the U.S. for centuries, it is essential to understand the experiences of underserved and marginalized people. Read More | | By Ed Silverman BRYAN R. SMITH/AFP via Getty Images A former AstraZeneca communications executive was accused of insider trading in connection with a partnership with Daiichi Sankyo. Read More | |
No comments